Comparing Venetoclax in Combination with Hypomethylating Agents to Hypomethylating Agent-Based Therapies for Treatment Naive TP53-mutated Acute Myeloid Leukemia: Results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

Talha Badar,Ahmad Nanaa,Ehab Atallah,Rory M. Shallis,Sacchi de Camargo Correia Guilherme,Aaron D. Goldberg,Antoine N. Saliba,Anand Patel,Jan P. Bewersdorf,Adam S. DuVall,Danielle Bradshaw,Yasmin Abaza,Guru Subramanian Guru Murthy,Neil Palmisiano,Amer M. Zeidan,Vamsi Kota,Mark R. Litzow

Blood Cancer Journal（2024）

Division of Hematology-Oncology

Cited 6|Views13

Key words

Treatment Outcomes

Bibtex

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Chat Paper

Summary is being generated by the instructions you defined